USE OF IMPELLA 5.0 AS BRIDGE TO LVAD IN CARDIOGENIC SHOCK: REPORT OF TWO CASES

被引：0
|
作者：
Marcelli, Chiara [1 ]
Sabatino, Mario [1 ]
Spitaleri, Giosafat [1 ]
Masetti, Marco [1 ]
Martin-suarez, Sofia [1 ]
Loforte, Antonio [1 ]
Galie, Nazzareno [1 ]
Potena, Luciano [1 ]
机构：
[1] Policlin St Orsola, Bologna, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2022年 / 24卷
关键词：
D O I：
10.1093/eurheartjsupp/suac121.468
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1121
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Bridge To Decision Or Destination With Impella 5.0 And 5.5 In Cardiogenic Shock
    Agrawal, Nikhil
    Hameed, Fariha R.
    Kumar, Sachin
    Akkanti, Bindu
    Hussain, Rahat
    Jumean, Marwan F.
    Bhardwaj, Anju
    Nathan, Sriram
    Patel, Manish K.
    de Armas, Ismael A. Salas
    Akay, Mehmet H.
    Kar, Biswajit
    Gregoric, Igor D.
    [J]. JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S74 - S74
  • [2] Role of Tmcs with Impella as Bridge to LVAD After AMI Related Cardiogenic Shock
    Ajello, S.
    Pieri, M.
    Dormio, S.
    Baldetti, L.
    Altizio, S.
    Consolo, F.
    Nardelli, P.
    Ortalda, A.
    Scandroglio, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S348 - S348
  • [3] Outcomes With Impella 5.0 And 5.5 In Cardiogenic Shock
    Tonleu, Franck H. Azobou
    Zapata, David
    Daneshmand, Mani
    Staloch, Dustin
    Agrawal, Akanksha
    [J]. JOURNAL OF CARDIAC FAILURE, 2022, 28 (05) : S72 - S72
  • [4] Impella 5.0 supported oncological surgery as bridge to LVAD
    Montisci, Andrea
    Micheletto, Giancarlo
    Sibilio, Serena
    Donatelli, Francesco
    Tespili, Maurizio
    Banfi, Carlo
    Casilli, Francesco
    Cosseta, Daniele
    Miceli, Antonio
    Cirri, Silvia
    Pappalardo, Federico
    [J]. ESC HEART FAILURE, 2021, 8 (01): : 167 - 170
  • [5] Impella 5.0 Reduces Vasoactive Agents In Cardiogenic Shock
    Bashline, Michael
    Kola, Olivia
    Yunis, Adil
    Fowler, Jeffrey
    Hickey, Gavin
    [J]. JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S50 - S50
  • [6] CLINICAL OUTCOMES AMONG IMPELLA 5.0/5.5 RECIPIENTS WITH CARDIOGENIC SHOCK: A REPORT FROM THE CARDIOGENIC SHOCK WORKING GROUP
    Fried, Justin
    Farr, MaryJane A.
    Kanwar, Manreet
    Garan, Arthur R.
    Hernandez-Montfort, Jaime
    Sinha, Shashank S.
    Sangal, Paavni
    Kong, Qiuyue
    Li, Borui
    Uriel, Nir
    Burkhoff, Daniel
    Kapur, Navin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 342 - 342
  • [7] Clinical Outcomes Among Impella 5.0/5.5 Recipients with Cardiogenic Shock: A Report from The Cardiogenic Shock Working Group
    Farr, M.
    Fried, J.
    Montfort, J. Hernandez
    Sinha, S.
    Kanwar, M.
    Garan, A.
    Uriel, N.
    Li, B.
    Kong, Q.
    Sangal, P.
    Burkoff, D.
    Kapur, N.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S27 - S28
  • [8] Comparative Clinical Outcomes with the Initial Use of Impella CP versus Impella 5.0 Devices in Patients with Severe Cardiogenic Shock
    Tank, Rikin
    Cheng, Richard
    Ramzy, Danny
    Esmailian, Fardad
    Kobashigawa, Jon
    Moriguchi, Jaime
    Arabia, Francisco
    Azarbal, Babak
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (18) : B227 - B228
  • [9] Management and outcome of patients supported with Impella 5.0 for refractory cardiogenic shock
    Philippe Gaudard
    Marc Mourad
    Jacob Eliet
    Norddine Zeroual
    Geraldine Culas
    Philippe Rouvière
    Bernard Albat
    Pascal Colson
    [J]. Critical Care, 19
  • [10] The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
    Tarabichi, Saeed
    Ikegami, Hirohisa
    Russo, Mark J.
    Lee, Leonard Y.
    Lemaire, Anthony
    [J]. JOURNAL OF CARDIOTHORACIC SURGERY, 2020, 15 (01)
12345